Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Objective: Chronic liver disease (CLD) is a major cause of mortality and morbidity worldwide. The aim of this study was to assess the overall and liver-related mortality and their predictors in patients with CLD using population data. Methods: The Third National Health and Nutrition Examination Survey (NHANES III) and linked mortality data were utilised. Participants from NHANES III (1988–1994) and their mortality status were updated by the Center for Disease Control (CDC) as of 31 December 2006. In this study, the aetiology of CLD was based on available serological tests and clinical data. Each diagnostic cohort was compared with a cohort without liver disease using stratum-specific χ 2 . The Cox proportional hazard model was used for analysis, and HRs adjusted for all major confounders; overall mortality and cause-specific mortality were calculated for each type of liver disease. All analyses were run using SAS-callable SUDAAN 10.0 functions using remote access to the CDC Research Data Center server with restricted use linked mortality data. Results: The study cohort included 15 866 NHANES III participants with complete clinical, demographic, laboratory and mortality follow-up data. Of these, 235 subjects had alcohol-related liver disease (ALD), 66 had chronic hepatitis B (CH-B), 264 had chronic hepatitis C (CH-C), 991 were presumed to have non-alcoholic fatty liver disease (NAFLD) and 505 had other liver disease. Additionally, 13 004 subjects without evidence of liver disease served as controls. The analysis shows that type II diabetes (DM) and/or insulin resistance (IR) are independent predictors of overall mortality in CH-B, NAFLD and ALD (p <0.05). Additionally, DM, IR, obesity and metabolic syndrome could be independent predictors of liver-related mortality in CH-C, NAFLD and ALD. Conclusions: Components of metabolic syndrome are associated with overall and liver-related mortality in subjects with CLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Angulo, P., Hui, J. M., Marchesini, G., Bugianesi, E., George, J., Farrell, G. C., Enders, F., Saksena, S., Burt, A. D., Bida, J. P., et al. (2007) · Hepatology · doi:10.1002/hep.21496 · Cited by 3,203
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890
Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
Angulo, P., Keach, J. C., Batts, K. P., & Lindor, K. D. (1999) · Hepatology · doi:10.1002/hep.510300604 · Cited by 1,610
Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors.
Wanless, I. R., & Lentz, J. S. (1990) · Hepatology · doi:10.1002/hep.1840120505 · Cited by 1,191
Heron, M. P., Hoyert, D. L., Murphy, S. L., Xu, J., Kochanek, K. D., & Tejada‐Vera, B. (2009) · PubMed · Cited by 909
Inoue, M. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.17.1871 · Cited by 561
Kawaguchi, T., Yoshida, T., Harada, M., Hisamoto, T., Nagao, Y., Ide, T., Taniguchi, E., Kumemura, H., Hanada, S., Maeyama, M., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63408-6 · Cited by 536
Hepatitis C infection and risk of diabetes: A systematic review and meta-analysis
White, D. L., Ratziu, V., & El-Serag, H. B. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.08.006 · Cited by 451
Nonalcoholic fatty liver disease in patients with type 2 diabetes
Younossi, Z. M., Gramlich, T., Matteoni, C. A., Boparai, N., & McCullough, A. J. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00014-x · Cited by 443
Self-citationLiver cirrhosis and diabetes: Risk factors, pathophysiology, clinical implications and management
Garcia-Compean, D., Jaquez-Quintana, J. O., Gonzalez-Gonzalez, J. A., & Maldonado-Garza, H. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.280 · Cited by 423
Risk factors of fibrosis in alcohol-induced liver disease
Raynard, B., Balian, A., Fallik, D., Capron, F., Bedossa, P., Chaput, J.-C., & Naveau, S. (2002) · Hepatology · doi:10.1053/jhep.2002.31782 · Cited by 392
Dietary fat content modifies liver fat in overweight nondiabetic subjects
Westerbacka, J., Lammi, K., Häkkinen, A.-M., Rissanen, A., Salminen, I., Aro, A., & Yki-Järvinen, H. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1983 · Cited by 379 · cited 1×
“Indeed, while metabolic conditions affect the liver, damage to hepatic tissue from steatosis and fibrosis is known to affect the development of insulin resistance (IR) independently of changes in adipose tissue.(10) Though confirmed by several well-designed clinical and experimental studies, this association has never…”
BackgroundDeaths: Final Data for 2003: (518032006-001)
Hoyert, D. L., Heron, M. P., Murphy, S. L., & Kung, H.-C. (2006) · PsycEXTRA Dataset · doi:10.1037/e518032006-001 · Cited by 362
Nonalcoholic fatty liver disease: A manifestation of the metabolic syndrome
KIM, C. H., & YOUNOSSI, Z. M. (2008) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.75.10.721 · Cited by 340
Self-citationMetabolic disturbances in non-alcoholic fatty liver disease
Byrne, C. D., Olufadi, R., Bruce, K. D., Cagampang, F. R., & Ahmed, M. H. (2009) · Clinical Science · doi:10.1042/cs20080253 · Cited by 258
Albanis, E., & Friedman, S. L. (2001) · Clinics in Liver Disease · doi:10.1016/s1089-3261(05)70168-9 · Cited by 183
Petta, S., Cammà, C., Marco, V. D., Alessi, N., Cabibi, D., Caldarella, R., Licata, A., Massenti, F., Tarantino, G., Marchesini, G., et al. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01813.x · Cited by 179
Impact of Diabetes on the Severity of Liver Disease
Hickman, I. J., & Macdonald, G. A. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.03.025 · Cited by 175
Cancer health disparities among Asian Americans: What we know and what we need to do
Chen, M. S. (2005) · Cancer · doi:10.1002/cncr.21501 · Cited by 173
Role of Diabetes Mellitus in the Etiology of Hepatocellular Carcinoma
Lagiou, P. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.13.1096 · Cited by 162
Jan, C.-F., Chen, C.-J., Chiu, Y.-H., Chen, L.-S., Wu, H.-M., Huang, C.-C., Yen, M.-F., & Chen, T. H.-H. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803204 · Cited by 132
Association Between Liver Fibrosis and Insulin Sensitivity in Chronic Hepatitis C Patients
Taura, N., Ichikawa, T., Hamasaki, K., Nakao, K., Nishimura, D., Goto, T., Fukuta, M., Kawashimo, H., Fujimoto, M., Kusumoto, K., et al. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00835.x · Cited by 90
de Lédinghen, V., Ratziu, V., Causse, X., Bail, B. L., Capron, D., Renou, C., Pilette, C., Oulès, V., Gelsi, È., Oberti, F., et al. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.05.008 · Cited by 88
Purohit, V., Russo, D., & Coates, P. M. (2004) · Alcohol · doi:10.1016/j.alcohol.2004.06.008 · Cited by 70
Impact of diabetes mellitus on prognosis of patients infected with hepatitis C virus
Kita, Y., Mizukoshi, E., Takamura, T., Sakurai, M., Takata, Y., Arai, K., Yamashita, T., Nakamoto, Y., & Kaneko, S. (2007) · Metabolism · doi:10.1016/j.metabol.2007.07.011 · Cited by 50
The prevalence of occult hepatitis B virus infection in type 2 diabetes mellitus patients
Demir, M., Serin, E., Göktürk, S., Ozturk, N. A., Kulaksızoğlu, S., & Ylmaz, U. (2008) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3282f55e1e · Cited by 49
Cited by
Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Hepatology · doi:10.1002/hep.25762 · Cited by 3,803
Self-citationRinella, M. E., Neuschwander-Tetri, B. A., Siddiqui, M. S., Abdelmalek, M. F., Caldwell, S., Barb, D., Kleiner, D. E., & Loomba, R. (2023) · Hepatology · doi:10.1097/hep.0000000000000323 · Cited by 2,667
Younossi, Z. M., Golabi, P., de Avila, L., Paik, J. M., Srishord, M., Fukui, N., Qiu, Y., Burns, L., Afendy, A., & Nader, F. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.06.021 · Cited by 2,235
Self-citationChalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.001 · Cited by 1,775
Self-citationTsochatzis, E. A., Bosch, J., & Burroughs, A. K. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60121-5 · Cited by 1,740
Metadata
- Authors
- Stepanova, M., Rafiq, N., & Younossi, Z. M.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2010-07-26
- Volume
- 59
- Issue
- 10
- Pages
- 1410-1415
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2097249828
- Cited by
- 303
- References
- 28
- FWCI
- 12.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.